BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2880199)

  • 1. Encephalopathy with rapid infusion ifosfamide/mesna.
    Perren TJ; Turner RC; Smith IE
    Lancet; 1987 Feb; 1(8529):390-1. PubMed ID: 2880199
    [No Abstract]   [Full Text] [Related]  

  • 2. Avoiding ifosfamide/mesna encephalopathy.
    Meanwell CA; Kelly KA; Blackledge G
    Lancet; 1986 Aug; 2(8503):406. PubMed ID: 2874408
    [No Abstract]   [Full Text] [Related]  

  • 3. Irreversible encephalopathy with ifosfamide/mesna.
    Salloum E; Flamant F; Ghosn M; Taleb N; Akatchereian C
    J Clin Oncol; 1987 Aug; 5(8):1303-4. PubMed ID: 3114437
    [No Abstract]   [Full Text] [Related]  

  • 4. Ifosfamide/mesa and encephalopathy.
    Cantwell BM; Harris AL
    Lancet; 1985 Mar; 1(8431):752. PubMed ID: 2858016
    [No Abstract]   [Full Text] [Related]  

  • 5. [Encephalopathy caused by an ifosfamide-mesna combination].
    Beuzeboc P; Dorval T; Garcia-Giralt E; Jouve M; Livartowski A; Palangie T; Scholl S; Pouillart P
    Presse Med; 1988 Apr; 17(12):591-2. PubMed ID: 2967486
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal encephalopathy with ifosfamide/mesna.
    Verdeguer A; Castel V; Esquembre C; Ferris J; Fernandez JM; Ruiz JG
    Pediatr Hematol Oncol; 1989; 6(4):383-5. PubMed ID: 2518327
    [No Abstract]   [Full Text] [Related]  

  • 7. Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.
    Ghosn M; Carde P; Leclerq B; Flamant F; Friedman S; Droz JP; Hayat M
    Bull Cancer; 1988; 75(4):391-2. PubMed ID: 3132998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide, mesna, and encephalopathy.
    Lancet; 1985 Jun; 1(8442):1398-9. PubMed ID: 2861351
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.
    Husband DJ; Watkin SW
    Lancet; 1988 May; 1(8594):1116. PubMed ID: 2896952
    [No Abstract]   [Full Text] [Related]  

  • 10. Encephalopathy associated with ifosphamide/mesna therapy.
    Meanwell CA; Blake AE; Latief TN; Blackledge G; Mould JJ; Blake DR; Shaw IC; Honigsberger L; Spooner D; Williams AC
    Lancet; 1985 Feb; 1(8425):406-7. PubMed ID: 2857462
    [No Abstract]   [Full Text] [Related]  

  • 11. Ifosfamide/mesna encephalopathy.
    McCallum AK
    Lancet; 1987 Apr; 1(8539):987. PubMed ID: 2882385
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of ifosfamide/mesna associated encephalopathy.
    Meanwell CA; Blake AE; Kelly KA; Honigsberger L; Blackledge G
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):815-9. PubMed ID: 3095121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe renal failure following high-dose ifosfamide and mesna.
    Willemse PH; de Jong PE; Elema JD; Mulder NH
    Cancer Chemother Pharmacol; 1989; 23(5):329-30. PubMed ID: 2495864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.
    Steger GG; Dittrich C; Schlappack O; Mader R; Herold C; Brade WP; Keller A; Moser K
    J Cancer Res Clin Oncol; 1988; 114(6):602-4. PubMed ID: 3144554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide by continuous infusion to prevent encephalopathy.
    Cerny T; Castiglione M; Brunner K; Küpfer A; Martinelli G; Lind M
    Lancet; 1990 Jan; 335(8682):175. PubMed ID: 1967471
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of advanced soft tissue and osteogenic sarcomas with continuous infusion of ifosfamide and mesna.
    Klein HO; Dias Wickramanayake P; Coerper C; Christian E
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S19. PubMed ID: 3102091
    [No Abstract]   [Full Text] [Related]  

  • 17. Mesna: continuous or bolus infusion?
    Willemse PH; de Vries EG
    J Clin Oncol; 1989 Jun; 7(6):817-9. PubMed ID: 2497231
    [No Abstract]   [Full Text] [Related]  

  • 18. Infusion of ifosfamide plus mesna.
    Rowland CG; Bradford E; Adams P; Haines-Nutt RP; Jakobson K
    Lancet; 1984 Aug; 2(8400):468. PubMed ID: 6147537
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer.
    Cantwell BM; Harris AL; Bozzino JM
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S29. PubMed ID: 3028660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nursing implications in the administration of ifosfamide and mesna.
    Richters JE
    Oncol Nurs Forum; 1990; 17(2):276. PubMed ID: 2107534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.